Helix BioMedix, Inc.
HXBM
$7.18
-$0.01-0.14%
OTC PK
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Net Income | -785.20K | -668.30K | -581.80K | -548.40K | -605.60K |
| Total Depreciation and Amortization | 22.90K | 22.10K | 23.10K | 26.60K | 27.80K |
| Total Amortization of Deferred Charges | 50.70K | 50.10K | 12.10K | -- | -- |
| Total Other Non-Cash Items | 19.60K | 67.90K | 142.90K | 20.70K | 29.20K |
| Change in Net Operating Assets | 180.10K | 130.80K | -121.70K | 116.70K | -2.50K |
| Cash from Operations | -511.80K | -397.40K | -525.40K | -384.30K | -551.10K |
| Capital Expenditure | -10.70K | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 6.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -27.00K | -- | 0.00 | -42.00K |
| Cash from Investing | -10.70K | -27.00K | -- | 6.00K | -42.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -522.60K | -424.40K | -525.40K | -378.30K | -593.10K |